Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 15 hours agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter ...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 1 day agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts’ expectations ...
J.P. Morgan downgrades Metagenomi over Moderna deal termination (NASDAQ:MGX)
Seeking Alpha· 19 hours agoJ.P. Morgan has lowered its rating of Metagenomi (NASDAQ:MGX) to neutral, citing the recent...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 1 day agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Moderna Stock Rises on Vaccine Launch Target, Above-Consensus 1Q
Market Watch· 23 hours agoBy Dean Seal Shares of Moderna rose after the company set a fall target date for the launch of its next vaccine and posted better first-quarter results than...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 1 day agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Moderna Inc (MRNA, Financial) reported substantial clinical progress with ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 19 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street's Radar
InvestorPlace· 3 hours agoPharma stocks and massive potential go hand in hand. With devastating diseases like cancer, diabetes...